Liver Diseases  >>  Cometriq (cabozantinib capsule)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cometriq (cabozantinib capsule) / Exelixis, Ipsen
NCT01493869: Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects

Completed
1
26
US
cabozantinib, XL184
Exelixis
Healthy, Hepatic Impairment
05/14
08/14

Download Options